COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2019

Mar 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2019-03-15

Reporting Person: Kuhlmann Shirley R. (EVP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-15	Common Stock	F	1470	$16.98	Disposed	44130	Direct

Footnotes

F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.